In cancer, PADI1 can promote tumor proliferation, migration, invasion and drug resistance by promoting energy metabolism and signal transduction (MEK1-ERK1/2-MMP2, ERK1/2-p38 and PADI1-MAPK-MMP2/9), thus it acts as oncogene in cancer. This evidence concerns the gene MAPK3 and cancer.